Marksans Pharma Wins FDA Approval for Zyrtec Copycat

Marksans Pharma Wins FDA Approval for Zyrtec Copycat

Indian generic drugmaker Marksans Pharma has won FDA approval for its cetirizine hydrochloride tablets.

The antihistamine is indicated for the treatment of allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes and running nose.

The 10 mg and 5 mg tablets will be marketed over the counter under store brand labels and is comparable to Johnson & Johnson’s Zyrtec.

January 14, 2022

https://www.fdanews.com/


0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company